Leaflet PROHANCE 0.5mmol / ml solution for injection
Indicated for: diagnostic imaging contrast enhancement
Route of administration: injectable
Substance: gadoteridol (contrast agent)
ATC: V08CA04 (Various | Magnetic resonance imaging contrast media | Paramagnetic contrast media)
Risk of severe allergic reaction. Seek urgent medical help if serious symptoms occur.
This medicine is subject to additional monitoring.
This medicine may affect the kidneys.
Gadoteridol is a contrast agent used in magnetic resonance imaging (MRI) to enhance the visualization of internal structures, including the brain, spine, and other organs. It is a gadolinium-based contrast agent.
This medication is administered intravenously and is used for diagnosing neurological, vascular, or oncological conditions.
Adverse reactions may include nausea, dizziness, headache, or injection site reactions. In rare cases, severe allergic reactions or nephrogenic systemic fibrosis may occur in patients with kidney impairment.
It is important to discuss your medical history, especially kidney conditions, with your doctor before receiving gadoteridol.
General data about PROHANCE 0.5mmol / ml
- Substance: gadoteridol
- Date of latest medicines list: 01-06-2026
- Product code: W66183004
- Concentration: 0.5mmol / ml
- Pharmaceutical form: solution for injection
- Quantity: 1
- Product type: Original
- Price: 229.48 RON
- Prescription status: P-RF - Medicines dispensed with a medical prescription that is retained by the pharmacy and cannot be renewed.